Skip to main content
OpenTrials
Completed

NCT Number: NCT01616069

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiopulmonary Bypass Graft Cardiovascular Diseases Heart Diseases Heart Failure

Age range

45 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

National Institute of Cardiology / Ministry of Health

Rio de Janeiro, 3600-100, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sinusal ritmus
  • EF > 35%
  • Elective CABG surgery

Exclusion criteria

  • No accept
  • Severe valvular regurgitation or stenoses
  • Chest pain
  • Cardiogenic shock

Treatment and study plan

epinephrine and levosimendan

Drug

epinephrine (0,06mcg/kg/min), levosimendan (0,2 mcg/kg/min)

Primary outcomes

  1. Systolic and diastolic heart function

    Time frame: Two years

    Assessment the systolic and diastolic heart function

Secondary outcomes

  1. Mortality after CABAG

    Time frame: Two years

    Assessment mortality after CABAG

Sponsors and collaborators

Lead sponsor

Federal University of Juiz de Fora

Other

Collaborators

  • National Institute of Cardiology/Ministry of Health
  • Universidade Federal do Rio de Janeiro

Registry information

Official study title

Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Jun 11, 2012
Registry last updated
Jun 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.